Search results
Apr 6, 2023 · Shares of Heron Therapeutics (HRTX 1.12%) stormed higher by 47% over the first 3 1/2 days of trading this week, according to data provided by S&P Global Market Intelligence. The big gain came in...
- George Budwell
Jan 24, 2024 · Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer. The company develops products by using its proprietary Biochronomer...
Dec 9, 2021 · Heron Therapeutics (HRTX 2.42%) saw its shares rise 14.9% this week. The stock, which closed at $8.68 last Friday, climbed to as high as $9.97 on Thursday.
Apr 6, 2023 · Shares of Heron Therapeutics (HRTX -10.36%) were up more than 19% early Thursday afternoon. The biopharmaceutical company, which has been focusing on post-surgery therapeutics, has been on a...
3 days ago · Congress Park Capital LLC raised its position in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) by 25.3% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,978,078 shares of the biotechnology company's stock. October 11, 2024 | marketbeat.com.
- 345 N Reid Place, Suite 620, Sioux Falls, 57103, SD
- (844) 978-6257
Oct 25, 2024 · Get a real-time Heron Therapeutics, Inc. (HRTX) stock price quote with breaking news, financials, statistics, charts and more.
People also ask
What was Heron Therapeutics' stock price in 2024?
Is Heron Therapeutics a good stock to buy?
Who is Heron Therapeutics?
When did Heron Therapeutics (hrtx) announce earnings results?
When did Heron Therapeutics change its name?
What is the 12-month price forecast for heron Therapeutics (hrtx)?
4 days ago · Should You Buy or Sell Heron Therapeutics Stock? Get The Latest HRTX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
